Article info

Download PDFPDF
Extended report
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

Authors

  1. Correspondence to Dr Jens Klotsche, German Rheumatism Research Centre, a Leibniz Institute, Chariteplatz 1, Berlin 10117, Germany; Jens.Klotsche{at}drfz.de
View Full Text

Citation

Klotsche J, Niewerth M, Haas J, et al
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

Publication history

  • Received October 7, 2014
  • Revised December 16, 2014
  • Accepted April 5, 2015
  • First published April 29, 2015.
Online issue publication 
April 07, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.